Hematology / Oncology Fellowship

***In order to be considered for an interview, all applications must be completed (with ALL documentation) on or before December 31, 2015.

The Cancer and Blood Diseases Institute at Cincinnati Children’s offers the breadth and depth of experience you will need to prepare for a successful clinical and scientific career in pediatric hematology-oncology. Our cancer program is ranked No. 12 in the country in the 2016-17 list of Best Children’s Hospitals published by U.S. News & World Report. Our comprehensive clinical center, world-class faculty and high-tech research programs provide an excellent setting for this specialized training. The Hematology / Oncology Fellowship Training Program is an ACGME-accredited program with a curriculum incorporating an intensive three-year program that provides clinical and research training leading to eligibility for subspecialty certification by the American Board of Pediatrics.

Cincinnati Children’s is a leader in clinical, translational and basic science research. More than 300 faculty members have secured more than $100 million in National Institutes of Health funding, with a total extramural funding of $120 million and an annual research budget of $225 million. Cincinnati Children’s ranks second in the nation among children’s hospitals in terms of NIH funding. Total pediatric research space is about a million square feet, the latest phase of which opened in 2007. The University of Cincinnati College of Medicine, across the street, is an additional source for professional collaboration and interaction.

Fellowship Training Program Overview

The Cancer and Blood Diseases Institute provides fellows comprehensive clinical training and opportunities for basic, translational and clinical research in all areas of hematology-oncology. The Division of Experimental Hematology and Cancer Biology provides fellows with training in basic and translational research in hematology-oncology. Together they provide a unique opportunity to train fellows in basic, translational and clinical research, epitomizing the concept of “bench to bedside” research.

A Message from Our New Program Director

Read an important message from our new program director.